Secondary Schizophrenia (129 page)

64. Rovet J. F., Buchanan L. (1999)

deletion syndrome: update and

group. Br J Psychiatry, 2005.

Turner syndrome: a cognitive

review of the clinical features,

186
:115–20.

neuroscience approach. In

cognitive-behavioral spectrum,

81. Cannon M., Caspi A., Moffitt T.

Neurodevelopmental Disorders,

and psychiatric complications.

E.,
et al.
Evidence for early-

Tager F. (Ed.). Cambridge, Mass.:

Am J Med Genet, 2000.
97
:128–
childhood, pan-developmental

The MIT Press, pp. 223–50.

35.

impairment specific to

65. Sobin C., Kiley-Brabeck K.,

73. Arnold P. D., Siegel-Bartelt J.,

schizophreniform disorder:

Karayiorgou M. Associations

Cytrynbaum C.,
et al.

results from a longitudinal birth

between prepulse inhibition and

Velocardio-facial syndrome:

cohort. Arch Gen Psychiatry, 2002.

executive visual attention in

implications of microdeletion

59
:449–56.

children with the 22q11 deletion

22q11 for schizophrenia and

82. Davalos D. B., Compagnon N.,

syndrome. Mol Psychiatry, 2005b.

mood disorders. Am J Med Genet,

Heinlein S.,
et al.

10
:553–62.

2001.
105
:354–62.

Neuropsychological deficits in

66. Baker K., Baldeweg T.,

74. Gothelf D., Presburger G., Zohar

children associated with increased

Sivagnanasundaram S.,
et al.

A. H.,
et al.
Obsessive-compulsive
familial risk for schizophrenia.

COMT Val108/158 Met modifies

disorder in patients with

Schizophr Res, 2004.
67
:123–30.

mismatch negativity and cognitive

velocardiofacial (22q11 deletion)

83. Mitnick R. J., Bello J. A.,

function in 22q11 deletion

syndrome. Am J Med Genet, B

Shprintzen R. J. Brain anomalies

syndrome. Biol Psychiatry, 2005.

Neuropsychiatr Genet, 2004.

in velocardio-facial syndrome.

323

58
:23–31.

126
:99–105.

Am J Med Genet, 1994.
54
:100–6.

Organic Syndromes of Schizophrenia – Section 3

84. Bingham P. M., Zimmerman R.

schizophrenia? Am J Psychiatry,

101. Antshel K. M., Conchelos J.,

A., Donald-McGinn D.,
et al.

2001.
158
:447–53.

Lanzetta G.,
et al.
Behavior and
Enlarged Sylvian fissures in

93. Simon T. J., Ding L., Bish J. P., et
corpus callosum morphology

infants with interstitial deletion of

al. Volumetric, connective, and

relationships in velocardiofacial

chromosome 22q11. Am J Med

morphologic changes in the

syndrome (22q11.2 deletion

Genet, 1997.
74
:538–43.

brains of children with

syndrome). Psychiatry Res, 2005.

85. Vataja R., Elomaa E. Midline

chromosome 22q11.2 deletion

138
:235–45.

brain anomalies and

syndrome: an integrative study.

102. Keshavan M. S., Dick E.,

schizophrenia in people with

Neuroimage, 2005b.
25
:169–80.

Mankowski I.,
et al.
Decreased left
CATCH 22 syndrome. Br J

94. Bearden C. E., van Erp T. G.,

amygdala and hippocampal

Psychiatry, 1998.
172
:518–20.

Dutton R. A.,
et al.
Mapping

volumes in young offspring at risk

86. Chow E. W., Mikulis D. J.,

cortical thickness in children with

for schizophrenia Schizophr Res,

Zipursky R. B.,
et al.
Qualitative
22q11.2 deletions. Cereb Cortex,

2002a.
58
:173–83.

MRI findings in adults with 22q11

2007.
17
:1889–98. [Epub Oct 20,
103. Keshavan M. S., Diwadkar V. A.,

deletion syndrome and

2006.]

Harenski K.,
et al.
Abnormalities
schizophrenia. Biol Psychiatry,

95. Debbane M., Schaer M.,

of the corpus callosum in first

1999.
46
:1436–42.

Farhoumand R.,
et al.

episode, treatment naive

schizophrenia. J Neurol Neurosurg

87. Shashi V., Muddasani S., Santos C.

Hippocampal volume reduction

Psychiatry, 2002b.
72
:757–60.

C.,
et al.
Abnormalities of the

in 22q11.2 deletion syndrome.

corpus callosum in nonpsychotic

Neuropsychologia, 2006b.

104. Bearden C. E., van Erp T. G.,

children with chromosome 22q11

44
:2360–5.

Monterosso J. R.,
et al.
Regional
deletion syndrome. Neuroimage,

brain abnormalities in 22q11.2

96. Sugama S., Bingham P. M., Wang

2004.
21
:1399–406.

deletion syndrome: association

P. P.,
et al.
Morphometry of the
with cognitive abilities and

88. van A. T., Daly E., Robertson D.,

head of the caudate nucleus in

behavioral symptoms.

et al.
Structural brain

patients with velocardiofacial

Neurocase, 2004b.
10
:198–206.

abnormalities associated with

syndrome (del 22q11.2). Acta

deletion at chromosome 22q11:

Paediatr, 2000.
89
:546–9.

105. Feinberg I. Schizophrenia: caused

quantitative neuroimaging study

by a fault in programmed synaptic

97. Eliez S., Barnea-Goraly N.,

of adults with velocardio-facial

elimination during adolescence?

Schmitt J. E.,
et al.
Increased basal
syndrome. Br J Psychiatry, 2001.

J Psychiatr Res, 1982.
17
:319–34.

ganglia volumes in

178
:412–19.

velocardio-facial syndrome

106. Gothelf D., Frisch A., Munitz H.,

89. Usiskin S. I., Nicolson R.,

(deletion 22q11.2). Biol

et al.
Clinical characteristics of
Krasnewich D. M.,
et al.

Psychiatry, 2002.
52
:68–70.

schizophrenia associated with

Velocardiofacial syndrome in

velocardio-facial syndrome.

98. Kates W. R., Burnette C. P.,

childhood-onset schizophrenia.

Schizophr Res, 1999.
35
:105–12.

Bessette B. A.,
et al.
Frontal and
J Am Acad Child Adolesc

caudate alterations in

107. Bassett A. S., Chow E. W.,

Psychiatry, 1999.
38
:1536–43.

velocardiofacial syndrome

AbdelMalik P.,
et al.
The

90. Eliez S., Schmitt J. E., White C. D.,
(deletion at chromosome

schizophrenia phenotype in

et al.
Children and adolescents

22q11.2). J Child Neurol, 2004.

22q11 deletion syndrome. Am J

with velocardiofacial syndrome:

19
:337–42.

Psychiatry, 2003.
160
:1580–6.

a volumetric MRI study.

99. Campbell L. E., Daly E., Toal F.,

108. Meehl P. E. Toward an integrated

Am J Psychiatry, 2000.
157
:
et al.
Brain and behaviour in

theory of schizotaxia, schizotypy

409–15.

children with 22q11.2 deletion

and schizophrenia. J Personality

91. Katesa W. R., Burnettea C. P.

syndrome: a volumetric and

Disorders, 1990.
4
:1–99.

Posterior cortical white matter

voxel-based morphometry MRI

109. van A. T., Henry J., Morris R.,

anomalies in velocardiofacial

study. Brain, 2006.
129
:1218–28.

et al.
Cognitive deficits associated
syndrome. pp 1S-173S Biol

100. Kates W. R., Miller A. M.,

with schizophrenia in

Psychiatry, 2000.
47
(Suppl 1):
AbdulSabur N.,
et al.
Temporal

velocardio-facial syndrome.

S102–73S.

lobe anatomy and psychiatric

Schizophr Res, 2004b.
70
:223–32.

92. Eliez S., Blasey C. M., Schmitt E.

symptoms in velocardiofacial

110. Barnea-Goraly N., Menon V.,

J.,
et al.
Velocardiofacial

syndrome (22q11.2 deletion

Krasnow B.,
et al.
Investigation of
syndrome: are structural changes

syndrome). J Am Acad Child

white matter structure in

in the temporal and mesial

Adolesc Psychiatry, 2006.

velocardiofacial syndrome: a

324

temporal regions related to

45
:587–95.

diffusion tensor imaging study.

Chapter 24 – Velocardiofacial syndrome

Am J Psychiatry, 2003.

118. Sirotkin H., O’Donnell H.,

dopamine in the rat frontal

160
:1863–9.

DasGupta R.,
et al.
(1997)

cortex: reassessment of the effects

111. Chow E. W., Zipursky R. B.,

Identification of a new human

of antipsychotics on the dynamics

Mikulis D. J.,
et al.
Structural
catenin gene family member

of dopamine release and

brain abnormalities in patients

(ARVCF) from the region deleted

metabolism in the frontal cortex,

with schizophrenia and 22q11

in velocardio-facial syndrome.

nucleus accumbens, and striatum

deletion syndrome. Biol

Genomics, 1997.
41
:75–83.

by a simple two pool model.

Psychiatry, 2002.
51
:208–15.

119. Kurahashi H., Nakayama T.,

J Neurochem, 1994.
63
:972–9.

Osugi Y.,
et al.
Deletion mapping
112. van A. T., Daly E., Henry J.,
et al.

128. Weinberger D. R., Egan M. F.,

of 22q11 in CATCH22 syndrome:

Brain anatomy in adults with

Bertolino A.,
et al.
Prefrontal

identification of a second critical

velocardiofacial syndrome with

neurons and the genetics of

region. Am J Hum Genet, 1996.

and without schizophrenia:

schizophrenia. Biol Psychiatry,

58
:1377–81.

preliminary results of a structural

2001.
50
:825–44.

magnetic resonance imaging

120. Kurahashi H., Tsuda E., Kohama

129. Aksoy S. , Klener J.,

study. Arch Gen Psychiatry, 2004a.

R.,
et al.
Another critical region
Weinshilboum R. M. Catechol

61
:1085–96.

for deletion of 22q11: a study of

O-methyltransferase

100 patients. Am J Med Genet,

113. Gothelf D., Gruber R., Presburger

pharmacogenetics: photoaffinity

1997.
72
:180–5.

G.,
et al.
Methylphenidate

labelling and western blot analysis

treatment for

121. Karayiorgou M., Gogos J. A. The

of human liver samples.

attention-deficit/hyperactivity

molecular genetics of the

Pharmacogenetics, 1993.
3
:
disorder in children and

22q11-associated schizophrenia.

116–22.

adolescents with velocardiofacial

Brain Res Mol Brain Res, 2004.

130. Gogos J. A., Morgan M., Luine V.,

syndrome: an open-label study.

132
:95–104.

et al.
Catechol-O-methyl-

J Clin Psychiatry, 2003.
64
:
122. Carey J. C., Viskochil D. H.

transferase-deficient mice exhibit